EMD-17515

Single-particle
1.9 Å
EMD-17515 Deposition: 30/05/2023
Map released: 20/03/2024
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-17515

Cryo-EM structure of CAK in complex with inhibitor ICEC0768

EMD-17515

Single-particle
1.9 Å
EMD-17515 Deposition: 30/05/2023
Map released: 20/03/2024
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Homo sapiens
Sample: CDK-activating kinase
Fitted models: 8p72 (Avg. Q-score: 0.692)

Deposition Authors: Cushing VI , Koh AF , Feng J, Jurgaityte K , Bahl AK, Ali S , Kotecha A , Greber BJ
High-resolution cryo-EM of the human CDK-activating kinase for structure-based drug design.
PUBMED: 38480681
DOI: doi:10.1038/s41467-024-46375-9
ISSN: 2041-1723
Abstract:
Rational design of next-generation therapeutics can be facilitated by high-resolution structures of drug targets bound to small-molecule inhibitors. However, application of structure-based methods to macromolecules refractory to crystallization has been hampered by the often-limiting resolution and throughput of cryogenic electron microscopy (cryo-EM). Here, we use high-resolution cryo-EM to determine structures of the CDK-activating kinase, a master regulator of cell growth and division, in its free and nucleotide-bound states and in complex with 15 inhibitors at up to 1.8 Å resolution. Our structures provide detailed insight into inhibitor interactions and networks of water molecules in the active site of cyclin-dependent kinase 7 and provide insights into the mechanisms contributing to inhibitor selectivity, thereby providing the basis for rational design of next-generation therapeutics. These results establish a methodological framework for the use of high-resolution cryo-EM in structure-based drug design.